Literature DB >> 6418007

Morquio B syndrome: a primary defect in beta-galactosidase.

G T van der Horst, W J Kleijer, A T Hoogeveen, J G Huijmans, W Blom, O P van Diggelen.   

Abstract

Fibroblasts from patients with Morquio B syndrome contain normal numbers of beta-galactosidase molecules with normal turnover but strongly reduced activity per enzyme molecule. Various substrate affinities are abnormal: the Km for methylum belliferyl (MU)-beta-galactoside is 4-10-fold elevated and affinity for keratan sulphate and oligosaccharides, isolated from Morquio B urine, was not detectable. In contrast, these substrate affinities are normal for beta-galactosidase in adult type GM1-gangliosidosis fibroblasts. Cell hybridization studies demonstrate that Morquio B syndrome and infantile and adult type GM1-gangliosidosis belong to the same complementation group. From these results we conclude that Morquio B syndrome is caused by a mutation in the structural gene for beta-galactosidase, which is allelic to the mutations in infantile and adult type GM1-gangliosidosis. Urinary excretion of keratan sulphate and oligosaccharides is abnormal in Morquio B syndrome but normal in adult type GM1-gangliosidosis. The catalytic properties of beta-galactosidase in Morquio B syndrome and GM1-gangliosidosis provide a possible explanation for the distinct clinical manifestations in these disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418007     DOI: 10.1002/ajmg.1320160215

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

1.  Morquio-B syndrome (MPS-IV B) associated with beta-galactosidase deficiency in two siblings.

Authors:  Jayesh J Sheth; Frenny J Sheth; Raktima Bhattacharya
Journal:  Indian J Pediatr       Date:  2002-01       Impact factor: 1.967

2.  The skeletal phenotype of intermediate GM1 gangliosidosis: Clinical, radiographic and densitometric features, and implications for clinical monitoring and intervention.

Authors:  Carlos R Ferreira; Debra S Regier; Robin Yoon; Kristen S Pan; Jean M Johnston; Sandra Yang; Jürgen W Spranger; Cynthia J Tifft
Journal:  Bone       Date:  2019-11-06       Impact factor: 4.398

3.  A clinical biochemist's view of the investigation of suspected inherited metabolic disease.

Authors:  W Blom; J G Huijmans; G B van den Berg
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency.

Authors:  G M Mancini; A T Hoogeveen; H Galjaard; J E Mansson; L Svennerholm
Journal:  Hum Genet       Date:  1986-05       Impact factor: 4.132

5.  Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A).

Authors:  M Iwamoto; Y Nawa; I H Maumenee; J Young-Ramsaran; R Matalon; W R Green
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

6.  The lesions of an ovine lysosomal storage disease. Initial characterization.

Authors:  R D Murnane; D J Prieur; A J Ahern-Rindell; S M Parish; L L Collier
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

7.  Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.

Authors:  A Hinek; S Zhang; A C Smith; J W Callahan
Journal:  Am J Hum Genet       Date:  2000-06-06       Impact factor: 11.025

8.  Beta-galactosidase-deficient human fibroblasts: uptake and processing of the exogenous precursor enzyme expressed by stable transformant COS cells.

Authors:  A Oshima; K Itoh; Y Nagao; H Sakuraba; Y Suzuki
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

9.  A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses.

Authors:  Eveline J Langereis; Tom Wagemans; Wim Kulik; Dirk J Lefeber; Henk van Lenthe; Esmee Oussoren; Ans T van der Ploeg; George J Ruijter; Ron A Wevers; Frits A Wijburg; Naomi van Vlies
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  The levels of urinary glycosaminoglycans of patients with attenuated and severe type of mucopolysaccharidosis II determined by liquid chromatography-tandem mass spectrometry.

Authors:  Ryuichi Mashima; Eri Sakai; Misa Tanaka; Motomichi Kosuga; Torayuki Okuyama
Journal:  Mol Genet Metab Rep       Date:  2016-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.